Search results
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 4 hours agoBristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it...
Zacks Research Comments on Bristol-Myers Squibb’s FY2024 Earnings (NYSE:BMY)
ETF DAILY NEWS· 2 days agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Equities research analysts at Zacks Research issued their FY2024 earnings estimates for shares of Bristol-Myers Squibb in a report issued on Thursday ...
Is Bristol Myers' Dividend in Danger?
Motley Fool via Yahoo Finance· 4 days agoBristol Myers Squibb (NYSE: BMY) pays investors an attractive dividend, which yields an incredibly high rate of 5.5%. That's nearly four times the S&P...
Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint
The Wall Street Journal· 5 days agoBristol Myers Squibb said its trial evaluating a combination of cancer treatments failed to meet its...
Bristol Myers Squibb reports setback in lung cancer trial By Investing.com
Investing.com· 5 days agoBristol Myers Squibb (NYSE: NYSE:BMY) disclosed that its Phase 3 CheckMate -73L trial for treating a...
News Highlights: Top Company News of the Day - Friday at 7 PM ET
Morningstar· 5 days agoBristol Myers Squibb said its trial evaluating a combination of cancer treatments failed to meet its primary endpoint. The television company, which produces "The Walking Dead," cited "declines ...
Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug
Investor's Business Daily· 21 hours agoCytokinetics stock reversed higher Tuesday after safety worries clouded promising study results for...
Insider Buying: BOERNER CHRISTOPHER S., Bristol-Myers Squibb Co. [BMY] Chief Executive Officer...
Knox Daily· 6 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Bristol-Myers Squibb Co. shares valued at $99,560 were purchased ...
Nabla Bio secures $26m in Series A funding round
Pharmaceutical Technology via Yahoo Finance· 8 hours agoUS pharmaceutical company Nabla Bio has secured $26m for generative protein design in a Series A financing round led by Radical Ventures. The round...
Big Pharma layoffs continue, as Bristol-Myers Squibb cuts 2,200 jobs, $1.5B in costs
BenefitsPRO· 5 days agoAt a time when drugmakers Eli Lilly & Co. and Novo Nordisk are scrambling to meet demand for their...
